appears not to affect diabetic control
in most patients, but there are
occasional reports of hypoglycaemia or hyperglycaemia associated with its use. Itraconazole
caused modest increases in repaglinide
levels, but without affecting the control
of blood glucose levels. Itraconazole
has no effect on pioglitazone pharmacokinetics
No action is normally needed but warn patients to report any unexpected changes in blood glucose levels.